Dr. Agarwal’s Health Care Shines: A Closer Look at Q3 Financial Performance
Dr. Agarwal’s Health Care, a renowned eye care service provider, has recently made waves in the industry with its impressive financial performance for the third quarter of 2024. Led by CEO Dr. Adil Agarwal, the company reported a consolidated profit after tax (PAT) of ₹28.24 crore, showcasing a remarkable 25% year-on-year increase from the previous year. This surge in profitability was fueled by a significant rise in revenue from operations, which soared by 29% to ₹431 crore.
Expansion and Growth
One of the key highlights of Dr. Agarwal’s Health Care’s success story is its continuous expansion efforts. During the third quarter, the company added 12 new facilities to its network, bringing the total count to an impressive 221 by the end of December 2024. This strategic expansion has not only bolstered the company’s presence but also contributed to its overall revenue growth.
A Deeper Dive into Financials
Delving deeper into the financial numbers, it is evident that Dr. Agarwal’s Health Care has seen substantial growth across various segments. Revenue from operations in India experienced a robust 34.5% increase, reaching ₹390 crore, while revenue from mature facilities also saw a commendable growth of 16.6% year-on-year, totaling ₹291 crore. The company’s EBITDA rose by 26.3% to ₹128 crore, with an impressive EBITDA margin of 28.8%.
Impressive Nine-Month Performance
Looking at the broader picture, Dr. Agarwal’s Health Care’s performance over the nine months of FY2025 has been nothing short of impressive. The company reported a PAT of ₹68 crore, marking a significant 26.2% year-on-year increase, with a PAT margin of 5.3%. Revenue from operations for this period stood at ₹1,251 crore, reflecting a substantial 27.2% year-on-year growth.
Continued Expansion and Success
During the nine-month period, Dr. Agarwal’s Health Care added a total of 42 new facilities, including 35 newly established centers and seven acquired ones. The company also performed a staggering 213,602 surgeries, showcasing a remarkable 31.8% year-on-year increase. This growth trajectory is a testament to the company’s commitment to providing quality eye care services to a wider audience.
Expert Insights and Future Outlook
Reflecting on the company’s stellar performance, Dr. Adil Agarwal, the CEO of Dr. Agarwal’s Health Care, expressed his optimism for the future. He emphasized, “We have delivered a robust 29.5% growth in revenue and 26.3% in EBITDA in our maiden quarter post-listing. Strong patient footfalls and increased surgeries have driven our performance. While we continue our growth trajectory, we remain committed to sustainable and steady expansion in the coming quarters.”
In conclusion, Dr. Agarwal’s Health Care’s exceptional financial performance in the third quarter of 2024 underscores its position as a leader in the eye care industry. With a strong focus on expansion, innovation, and quality service delivery, the company is well-poised for continued success in the future.
